Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Epithelial Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT03905902
What this trial is testing

DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Carcinoma
SOTIO a.s.
Large-scale testing (Phase 3)Study completedNCT00113607
What this trial is testing

An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 672
Not applicableStudy completedNCT00248547
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Who this might be right for
Cancer
OHSU Knight Cancer Institute 40
Testing effectiveness (Phase 2)UnknownNCT01650376
What this trial is testing

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer

Who this might be right for
Stage III Ovarian CancerStage IV Ovarian CancerUterine Cancer
Swedish Medical Center 52
Testing effectiveness (Phase 2)Ended earlyNCT01296035
What this trial is testing

Panitumumab and Gemcitabine in Relapsed Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Women and Infants Hospital of Rhode Island 8
Testing effectiveness (Phase 2)Ended earlyNCT00926107
What this trial is testing

Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse

Who this might be right for
Ovarian Cancer
Hellenic Cooperative Oncology Group 9
Testing effectiveness (Phase 2)Study completedNCT03989336
What this trial is testing

The Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer

Who this might be right for
Ovarian Cancer
Chinese PLA General Hospital 84
Early research (Phase 1)Ended earlyNCT02649673
What this trial is testing

LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies

Who this might be right for
Small Cell Lung CancerOvarian Cancer
SCRI Development Innovations, LLC 34
Not applicableUnknownNCT06445621
What this trial is testing

Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Uppsala University Hospital 125
Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Early research (Phase 1)Looking for participantsNCT06483048
What this trial is testing

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+13 more
Mayo Clinic 12
Testing effectiveness (Phase 2)Study completedNCT02107950
What this trial is testing

Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma

Who this might be right for
Ovarian NeoplasmsOvarian Cancer (OvCa)Ovarian Epithelial Cancer
SOTIO a.s. 71
Testing effectiveness (Phase 2)Study completedNCT03602079
What this trial is testing

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Who this might be right for
HER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more
Klus Pharma Inc. 49
Testing effectiveness (Phase 2)Ended earlyNCT00189579
What this trial is testing

Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 45
Not applicableStudy completedNCT02163720
What this trial is testing

Ovarian Cancer Treatment Platinum-sensitive Relapse - Cohort Study (PROSPECTYON)

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 101
Testing effectiveness (Phase 2)UnknownNCT04983550
What this trial is testing

Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 126
Testing effectiveness (Phase 2)Study completedNCT00002943
What this trial is testing

Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer

Who this might be right for
Extragonadal Germ Cell TumorOvarian CancerTesticular Germ Cell Tumor+1 more
Wake Forest University Health Sciences 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06081595
What this trial is testing

Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment

Who this might be right for
Relapsed Ovarian Cancer
Jin Li 54
Early research (Phase 1)UnknownNCT04029909
What this trial is testing

A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian Epithelial CancerFallopian Tube CancerPrimary Peritoneal Cancer
Lee's Pharmaceutical Limited 12
Early research (Phase 1)Ended earlyNCT04562298
What this trial is testing

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-M23, a CAR-T Cell Therapy Targeting MSLN in Patients With Relapsed and Refractory Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Shanghai East Hospital 15
Next Page